Consequently, metabolic endotoxemia—persistently elevated circulating LPS levels—activates Toll-like receptor-4 (TLR4), an immune receptor that recognizes endotoxins, triggering NF-κB inflammation, signaling, and downstream inflammatory cascades, fostering systemic insulin resistance [11]. The gene discussed is INS; the disease is serum lipopolysaccharide activity.